Table 2.
Comparing baseline at the time of admission.
| S.N | Parameters | CVVH (N = 18) (pretreatment) | Conventional therapy (N = 24) (pretreatment) | p value |
|---|---|---|---|---|
| 1 | Age | 51.77 ± 12.02 | 53.50 ± 12.89 | >0.05 |
| 2 | Sex (M : F) | 13 : 5 | 17 : 7 | NS |
| 3 | Amylase | 635.55 ± 138.50 | 632.95 ± 145.14 | 0.953 |
| 4 | Lipase | 1067.22 ± 153.19 | 1066.91 ± 124.34 | 0.995 |
| 5 | CRP | 269.27 ± 75.77 | 268.79 ± 48.50 | 0.981 |
| 6 | IL-6 | 662.22 ± 166.43 | 663.25 ± 167.32 | 0.984 |
| 7 | IL-10 | 1104.05 ± 141.03 | 1105.58 ± 107.14 | 0.970 |
| 8 | TNF-alpha | 577.94 ± 104.03 | 578.95 ± 82.95 | 0.973 |
| 9 | Ranson score | 6.00 ± 1.45 | 5.79 ± 1.50 | 0.653 |
| 10 | APACHE-II score | 21.83 ± 1.75 | 22.66 ± 1.78 | 0.139 |
| 11 | Balthazar score | 7.27 ± 0.75 | 6.95 ± 0.75 | 0.181 |